Martin Kaiser

54PUBLICATIONS
226CO-AUTHORS
Medical biochemistry - inorganic elements and compoundsEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Jul 08, 2026
AI derived Whole-Body MRI metrics in multiple myeloma patients reveal unique insights into body composition and outcomes.

|Feb 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser

|Jan 16, 2026
Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries.

Alex Y Ge, William B Feldman, Martin F Kaiser

|Nov 27, 2025
Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network.

Niels W C J van de Donk, Philippe Moreau, Jesus F San-Miguel

|Oct 15, 2025
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma.

Niccolò Bolli, Mattia D'Agostino, Tina Bagratuni

|Oct 13, 2025
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform.

Adrian Mosquera Orgueira, Marta Sonia Gonzalez Perez, Mattia D'Agostino

Pageof 9

Frequent Collaborators

15 joint publications

Charlotte Pawlyn

15 joint publications

Gordon Cook

15 joint publications

Richard S Houlston

13 joint publications

David Cairns